BMO is in control at ACB and they’re going to get their money back out of them. Through sale of bad assets and a whole lot of retail investors buying ATM stock. Can ACB reduce their debt enough and leave enough of an operation left to have considerable value afterwards to Aphria? I’m thinking yes. 25mil per quarter of high margin medical sales is tantalizing. They seem to have a decent base in edibles/gummies although it’s a small market right now.
As much as weedstocks thinks Irwin is a slouch, it’s simply not true. His approach toward securing cash and solidifying the company financially is one of the main reasons APHA is in such a strong position now. Obviously the previous regime built the main assets, but I believe Irwin’s expertise has shown in how to mature the company. He’s not going to jump at a deal that drags down Aphria.
Just my personal opinion on Aphria’s interest in this “merger”. For now it’s as expected, wait and see. Gotta love to watch the ACB story unfold with a better idea of their structure.